Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Tuesday, June 16, 2015

Another Study Focused on Stem Cells and Autoimmune Diseases Shows Promise

Researchers at Monash University and the MIMR-PHI Institute of Medical Research in Australia recently proposed that specific human stem cells with immunomodulatory properties represent a new promising therapeutic strategy for diseases like multiple sclerosis (MS). The study was published in the Journal of Neuroinflammation and is entitled “Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
MS is a progressive neurodegenerative autoimmune disorder that results from an attack on the central nervous system by the body’s own immune system (through auto-reactive T cells), causing inflammation and damage to the myelin layer that covers and protects nerve fibers. Myelin loss leads to impairment in signal transmission along the nerve fibers, affecting motor function (coordination, balance, speech and vision), causing irreversible neurological disability and paralysis. It is estimated that more than 2.3 million people in the world suffer from the disease.
Recent research has shown that stem cells (cells with the potential to differentiate into several specialized cell types) like human amnion epithelial cells (hAECs), isolated from the amniotic membrane that covers the fetus, have the ability to modulate immune responses both in vitro and in vivo and to differentiate into clinically relevant cell types.
In the study, researchers analyzed the immunoregulatory properties of hAECs as a potential therapy for an MS-like disorder known as experimental autoimmune encephalomyelitis (EAE) in mice. The team assessed the immunomodulatory properties of hAECs in vitro and tested its therapeutic efficacy in EAE mice models. T cell response and phenotype were also determined.
 Keep CURRENT with MS Views and NewsOPT-IN here


No comments: